@article{bendaly_treatment_2017-1,
	title = {Treatment {Patterns} and {Early} {Outcomes} of {ALK}-{Positive} {Non}-{Small} {Cell} {Lung} {Cancer} {Patients} {Receiving} {Ceritinib}: {A} {Chart} {Review} {Study}},
	volume = {34},
	issn = {0741-238X, 1865-8652},
	shorttitle = {Treatment {Patterns} and {Early} {Outcomes} of {ALK}-{Positive} {Non}-{Small} {Cell} {Lung} {Cancer} {Patients} {Receiving} {Ceritinib}},
	url = {http://link.springer.com/10.1007/s12325-017-0527-6},
	doi = {10.1007/s12325-017-0527-6},
	abstract = {Introduction: This study aimed to provide the first real-world description of the characteristics, treatments, dosing patterns, and early outcomes of patients with ALK-positive non-small cell lung cancer (NSCLC) who received ceritinib in US clinical practice.},
	language = {en},
	number = {5},
	urldate = {2019-05-02},
	journal = {Advances in Therapy},
	author = {Bendaly, Edmond and Dalal, Anand A. and Culver, Kenneth and Galebach, Philip and Bocharova, Iryna and Foster, Rebekah and Sasane, Medha and Macalalad, Alexander R. and Guérin, Annie},
	month = may,
	year = {2017},
	pages = {1145--1156},
	file = {Bendaly et al. - 2017 - Treatment Patterns and Early Outcomes of ALK-Posit.pdf:/Users/neil.hawkins/Zotero/storage/KPXZZDYR/Bendaly et al. - 2017 - Treatment Patterns and Early Outcomes of ALK-Posit.pdf:application/pdf},
}

{"_id":"F2C4wtaBFgArR83Xx","bibbaseid":"bendaly-dalal-culver-galebach-bocharova-foster-sasane-macalalad-etal-treatmentpatternsandearlyoutcomesofalkpositivenonsmallcelllungcancerpatientsreceivingceritinibachartreviewstudy-2017","author_short":["Bendaly, E.","Dalal, A. A.","Culver, K.","Galebach, P.","Bocharova, I.","Foster, R.","Sasane, M.","Macalalad, A. R.","Guérin, A."],"bibdata":{"bibtype":"article","type":"article","title":"Treatment Patterns and Early Outcomes of ALK-Positive Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review Study","volume":"34","issn":"0741-238X, 1865-8652","shorttitle":"Treatment Patterns and Early Outcomes of ALK-Positive Non-Small Cell Lung Cancer Patients Receiving Ceritinib","url":"http://link.springer.com/10.1007/s12325-017-0527-6","doi":"10.1007/s12325-017-0527-6","abstract":"Introduction: This study aimed to provide the first real-world description of the characteristics, treatments, dosing patterns, and early outcomes of patients with ALK-positive non-small cell lung cancer (NSCLC) who received ceritinib in US clinical practice.","language":"en","number":"5","urldate":"2019-05-02","journal":"Advances in Therapy","author":[{"propositions":[],"lastnames":["Bendaly"],"firstnames":["Edmond"],"suffixes":[]},{"propositions":[],"lastnames":["Dalal"],"firstnames":["Anand","A."],"suffixes":[]},{"propositions":[],"lastnames":["Culver"],"firstnames":["Kenneth"],"suffixes":[]},{"propositions":[],"lastnames":["Galebach"],"firstnames":["Philip"],"suffixes":[]},{"propositions":[],"lastnames":["Bocharova"],"firstnames":["Iryna"],"suffixes":[]},{"propositions":[],"lastnames":["Foster"],"firstnames":["Rebekah"],"suffixes":[]},{"propositions":[],"lastnames":["Sasane"],"firstnames":["Medha"],"suffixes":[]},{"propositions":[],"lastnames":["Macalalad"],"firstnames":["Alexander","R."],"suffixes":[]},{"propositions":[],"lastnames":["Guérin"],"firstnames":["Annie"],"suffixes":[]}],"month":"May","year":"2017","pages":"1145–1156","file":"Bendaly et al. - 2017 - Treatment Patterns and Early Outcomes of ALK-Posit.pdf:/Users/neil.hawkins/Zotero/storage/KPXZZDYR/Bendaly et al. - 2017 - Treatment Patterns and Early Outcomes of ALK-Posit.pdf:application/pdf","bibtex":"@article{bendaly_treatment_2017-1,\n\ttitle = {Treatment {Patterns} and {Early} {Outcomes} of {ALK}-{Positive} {Non}-{Small} {Cell} {Lung} {Cancer} {Patients} {Receiving} {Ceritinib}: {A} {Chart} {Review} {Study}},\n\tvolume = {34},\n\tissn = {0741-238X, 1865-8652},\n\tshorttitle = {Treatment {Patterns} and {Early} {Outcomes} of {ALK}-{Positive} {Non}-{Small} {Cell} {Lung} {Cancer} {Patients} {Receiving} {Ceritinib}},\n\turl = {http://link.springer.com/10.1007/s12325-017-0527-6},\n\tdoi = {10.1007/s12325-017-0527-6},\n\tabstract = {Introduction: This study aimed to provide the first real-world description of the characteristics, treatments, dosing patterns, and early outcomes of patients with ALK-positive non-small cell lung cancer (NSCLC) who received ceritinib in US clinical practice.},\n\tlanguage = {en},\n\tnumber = {5},\n\turldate = {2019-05-02},\n\tjournal = {Advances in Therapy},\n\tauthor = {Bendaly, Edmond and Dalal, Anand A. and Culver, Kenneth and Galebach, Philip and Bocharova, Iryna and Foster, Rebekah and Sasane, Medha and Macalalad, Alexander R. and Guérin, Annie},\n\tmonth = may,\n\tyear = {2017},\n\tpages = {1145--1156},\n\tfile = {Bendaly et al. - 2017 - Treatment Patterns and Early Outcomes of ALK-Posit.pdf:/Users/neil.hawkins/Zotero/storage/KPXZZDYR/Bendaly et al. - 2017 - Treatment Patterns and Early Outcomes of ALK-Posit.pdf:application/pdf},\n}\n\n","author_short":["Bendaly, E.","Dalal, A. A.","Culver, K.","Galebach, P.","Bocharova, I.","Foster, R.","Sasane, M.","Macalalad, A. R.","Guérin, A."],"bibbaseid":"bendaly-dalal-culver-galebach-bocharova-foster-sasane-macalalad-etal-treatmentpatternsandearlyoutcomesofalkpositivenonsmallcelllungcancerpatientsreceivingceritinibachartreviewstudy-2017","role":"author","urls":{"Paper":"http://link.springer.com/10.1007/s12325-017-0527-6"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","dataSources":["ZaHtWavQhcwZqKLNF","iRRNaRs6FkffgErta","v8uQmZsBpiqycmskv"],"keywords":[],"search_terms":["treatment","patterns","early","outcomes","alk","positive","non","small","cell","lung","cancer","patients","receiving","ceritinib","chart","review","study","bendaly","dalal","culver","galebach","bocharova","foster","sasane","macalalad","guérin"],"title":"Treatment Patterns and Early Outcomes of ALK-Positive Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review Study","year":2017}